Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease

Case Studies in Neuroscience: A dissociation of balance and posture demonstrated by camptocormia.

Journal of neurophysiology·2017

Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: a randomized clinical trial.

BMC neurology·2015

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Parkinsonism & related disorders·2013

A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD.

Neurology·2010

Axial kinesthesia is impaired in Parkinson's disease: effects of levodopa.

Experimental neurology·2010

Higher level gait disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2007

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Elevated asymmetric dimethylarginine drives hematopoietic stem cell metabolic reprogramming and dysfunction in chronic kidney disease.

Experimental cell research·2026

The hidden burden of topical corticosteroid misuse: a systematic review of dermatologic complications.

Current medical research and opinion·2026

Curcumin Delivery Systems for Inflammatory Skin Application: A Review.

Phytotherapy research : PTR·2026

Engineered naringenin-loaded nanoscale coordination polymers for targeted treatment of acute kidney injury.

Materials today. Bio·2026

Modification of the existing maximum residue levels for propyzamide in oilseeds and honey.

EFSA journal. European Food Safety Authority·2026

Pulmonary Arterial Hypertension Associated With Chronic Mephedrone Use: A Case Report.

Pulmonary circulation·2026

Related Experiment Videos

Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease

Related Concept Videos

Case Studies in Neuroscience: A dissociation of balance and posture demonstrated by camptocormia.

Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: a randomized clinical trial.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD.

Axial kinesthesia is impaired in Parkinson's disease: effects of levodopa.

Higher level gait disorders.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Elevated asymmetric dimethylarginine drives hematopoietic stem cell metabolic reprogramming and dysfunction in chronic kidney disease.

The hidden burden of topical corticosteroid misuse: a systematic review of dermatologic complications.

Curcumin Delivery Systems for Inflammatory Skin Application: A Review.

Engineered naringenin-loaded nanoscale coordination polymers for targeted treatment of acute kidney injury.

Modification of the existing maximum residue levels for propyzamide in oilseeds and honey.

Pulmonary Arterial Hypertension Associated With Chronic Mephedrone Use: A Case Report.

Related Experiment Videos

Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease

Related Concept Videos

Related Articles